Shanghai Sonyt Biotechnology Co., Ltd. yog ib qho ntawm cov ua lag luam thiab cov neeg muag khoom ntawm cas: 1197810-60-8: glp-1 moiety los ntawm dulaglutide hauv Suav teb, kuj txhawb kev pabcuam kev cai. Txais tos rau cov lag luam wholesale bulk zoo cas: 1197810-60-8: glp-1 moiety los ntawm dulaglutide los ntawm peb lub hoobkas. Tiv tauj peb kom paub meej ntxiv.
| Khoom npe | CAS: 1197810-60-8: GLP-1 moiety los ntawm Dulaglutide |
| Kev piav qhia | Cov khoom no yog lub luag haujlwm tseem ceeb peptide moiety ntawm dulaglutide, ib ntus -optimized GLP-1 receptor agonist peptide. Nws ua rau kev tswj hwm cov metabolism hauv qabzib- nyob ntawm qhov tso tawm ntawm insulin, glucagon suppression, qeeb plab hnyuv thiab txo cov khoom noj los ntawm kev khi rau GLP-1 receptors nrog siab affinity. Nws cov kab ke tau raug hloov kho nrog qhov chaw- tshwj xeeb amino acid kev hloov pauv, txhim kho receptor khi ua haujlwm thiab peptidase degradation tsis kam. Conjugated rau IgG4 Fc fragment ntawm tus linker, nws muaj peev xwm ua kom ntev hauv vivo ib nrab -lub neej, uas yog lub hauv paus ua haujlwm rau cov nyhuv ntev ntawm dulaglutide. Cov peptide no tuaj yeem siv ncaj qha rau hauv cov kev sim xws li GLP-1 receptor function research, long-acting fusion protein drug design and glucose metabolism mechanism analysis, and is an important tool peptide for metabolic disease development drug. |
| Peptide Purity (HPLC, %) | 95% / 98% / 99% |
| Dawb puag molecular mis | C₁₄₉H₂₂₅N₃₉O₄₆ |
| Dawb puag molecular hnyav (Da) | 3382.6, siab dua rau daim ntawv ntsev |
| Hom qauv | Kev hloov kho GLP-1 analog peptide nrog rau qhov chaw tshwj xeeb hloov pauv kom zoo, pub dawb peptide / acetate ntsev |
Product Basic Information Table
| Khoom Lub Npe Lus Askiv | Product Abbreviation / Alias | Function Tags (comma-sib cais) | Core Structure | Molecular Formula | Exact Mass (Da) | Qhov nruab nrab MW (Da) | Daim ntawv ntsev | Ntev (aa) |
| GLP-1 moiety los ntawm Dulaglutide | Dulaglutide GLP-1 ua haujlwm peptide | GLP-1 receptor agonist, dulaglutide functional unit, kev tswj cov piam thaj, kev tshawb fawb ntev fusion peptide | Core functional peptide moiety ntawm dulaglutide, hloov kho tib neeg GLP-1 (7-}37) analog nrog rau qhov chaw tshwj xeeb hloov pauv los txhim kho receptor affinity thiab enzyme kuj; tuaj yeem txuas mus rau Fc fragment rau kev ua haujlwm ntev | Dawb peptide: C₁₄₉H₂₂₅N₃₉O₄₆ | 3380.63 | 3382.6 | Dawb peptide / acetate | 31 |
Physicochemical Solubility & Cia Parameters
| Khoom Code | Qhov tshwm sim | Ntev - Lub Sij Hawm Cia | Luv - Lub Sij Hawm Cia | Kev daws teeb meem | Khoom hmoov ruaj khov |
| PEB-DUG001 | hmoov dawb | Khaws ntawm -20 degree, kaw, qhuav thiab tiv thaiv los ntawm lub teeb. Aliquot kom tsis txhob rov qab khov-thaw mus. | ruaj khov rau 1 lub hlis ntawm 2-8℃nyob rau hauv kaw qhuav; nkoj ntawm cov pob khov nab kuab pom zoo. | ruaj khov rau 7 hnub ntawm 4 degree. Dawb soluble nyob rau hauv dilute acetic acid thiab acidic buffers. Protease degradation nyob rau hauv nruab nrab aqueous tov; npaj tshiab ua ntej siv los yog aliquot sterilely thiab khov. | ruaj khov rau 3 xyoos ntawm -20 degree, qhuav thiab tiv thaiv los ntawm lub teeb. |
Functional Description
| Khoom Code | Frontend Short Summary (rau cov npe tshawb nrhiav) | Cov lus piav qhia txog kev ua haujlwm lom neeg lom neeg | Cov cheeb tsam tshawb fawb (comma- cais) | Lub Hom Phiaj / Txoj Kev |
| PEB-DUG001 | Core functional peptide moiety ntawm dulaglutide, muaj zog heev GLP-1 receptor agonist peptide | Cov khoom no yog lub luag haujlwm tseem ceeb peptide moiety ntawm dulaglutide, ib ntus -optimized GLP-1 receptor agonist peptide. Nws ua rau kev tswj hwm cov metabolism hauv qabzib- nyob ntawm qhov tso tawm ntawm insulin, glucagon suppression, qeeb plab hnyuv thiab txo cov khoom noj los ntawm kev khi rau GLP-1 receptors nrog siab affinity. Nws cov kab ke tau raug hloov kho nrog qhov chaw- tshwj xeeb amino acid kev hloov pauv, txhim kho receptor khi ua haujlwm thiab peptidase degradation tsis kam. Conjugated rau IgG4 Fc fragment ntawm tus linker, nws muaj peev xwm ua kom ntev hauv vivo ib nrab -lub neej, uas yog lub hauv paus ua haujlwm rau cov nyhuv ntev ntawm dulaglutide. Cov peptide no tuaj yeem siv ncaj qha rau hauv cov kev sim xws li GLP-1 receptor function research, long-acting fusion protein drug design and glucose metabolism mechanism analysis, and is an important tool peptide for metabolic disease development drug. | GLP-1 receptor function study, long-acting fusion protein drug development, type 2 diabetes mechanism research, glucose metabolism regulation kawm, peptide drug design & optimization | Glucagon-zoo li peptide 1 receptor (GLP-1R); Glucose metabolism thiab kev tswj hwm kev noj zaub mov |
Cim npe nrov: cas:1197810-60-8: glp-1 moiety los ntawm dulaglutide, Tuam Tshoj cas:1197810-60-8: glp-1 moiety los ntawm dulaglutide manufacturers, lwm tus neeg, Hoobkas
